Mega Genomics Limited (HKG:6667)

Mega Genomics Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	424.56	415.59	490.26	518.29	399.83	239.1
Short-Term Investments	-	2.66	2.9	7.98	8.7	223.53
Trading Asset Securities	-	20.11	-	-	-	-
Cash & Short-Term Investments	424.56	438.36	493.16	526.27	408.53	462.63
Cash Growth	-7.59%	-11.11%	-6.29%	28.82%	-11.69%	115.93%
Accounts Receivable	242.87	223.32	90.06	115.88	184.82	203.63
Other Receivables	-	1.29	-	-	5.53	0.04
Receivables	242.87	224.6	90.06	115.88	190.36	203.67
Inventory	31.48	39.5	4.61	4.41	3.51	3.28
Prepaid Expenses	-	9.72	17.14	1.84	-	-
Other Current Assets	30.89	15.27	20.63	19.38	16.69	15.78
Total Current Assets	729.8	727.46	625.59	667.78	619.08	685.36
Property, Plant & Equipment	59.76	67.63	79.26	94.05	46.91	51.13
Long-Term Investments	35.28	30.9	30.8	29.6	30.03	30.2
Other Intangible Assets	1.42	0.61	0.77	0.92	0.83	0.81
Long-Term Deferred Tax Assets	3.7	3.61	2.06	4.2	5.97	2.81
Other Long-Term Assets	-	2.19	-	-	2.88	1.88
Total Assets	829.96	832.4	738.48	796.54	705.7	772.18

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	163.26	138.75	28.8	39.69	34.76	29.2
Accrued Expenses	-	9.93	7.55	6.58	7.95	15.68
Current Portion of Long-Term Debt	2.13	2.08	2	1.91	-	-
Current Portion of Leases	6.76	6.02	-	5.99	6.48	6.22
Current Income Taxes Payable	4.05	0.12	1.72	0.6	0.12	6.53
Current Unearned Revenue	0.45	41.36	49.22	52.87	10.46	10.7
Other Current Liabilities	28.14	1.78	1.35	2.06	21.48	1.47
Total Current Liabilities	204.78	200.04	90.64	109.71	81.25	69.79
Long-Term Debt	15.57	16.65	18.73	20.72	-	-
Long-Term Leases	4.07	4.63	13.68	19.94	4.51	5.35
Long-Term Unearned Revenue	-	0.15	0.75	1.35	1.95	2.55
Total Liabilities	224.42	221.46	123.8	151.72	87.7	77.69

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.14	0.14	0.15	0.15	0.16	0.13
Additional Paid-In Capital	-	275.63	334.37	385.57	394.49	228.69
Retained Earnings	-	6.38	6.38	6.38	101.63	119.24
Treasury Stock	-0.14	-	-27.98	-1.57	-	-
Comprehensive Income & Other	605.55	328.79	301.77	254.3	121.72	346.44
Shareholders' Equity	605.55	610.94	614.68	644.83	618	694.5
Total Liabilities & Equity	829.96	832.4	738.48	796.54	705.7	772.18

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	28.52	29.37	34.4	48.56	10.99	11.57
Net Cash (Debt)	396.04	408.99	458.75	477.71	397.55	451.06
Net Cash Growth	-5.61%	-10.85%	-3.97%	20.16%	-11.86%	135.56%
Net Cash Per Share	2.01	2.07	2.21	2.26	1.93	3.54
Filing Date Shares Outstanding	224.27	224.3	228.13	237.77	239.23	200
Total Common Shares Outstanding	224.27	224.3	228.13	237.77	239.23	200
Working Capital	525.02	527.42	534.95	558.07	537.83	615.57
Book Value Per Share	2.70	2.72	2.69	2.71	2.58	3.47
Tangible Book Value	604.13	610.33	613.91	643.91	617.16	693.69
Tangible Book Value Per Share	2.69	2.72	2.69	2.71	2.58	3.47
Land	-	34.74	34.74	-	-	-
Machinery	-	73.19	73.04	72.71	69.91	68.6
Construction In Progress	-	-	-	34.74	-	-
Leasehold Improvements	-	12.95	12.95	12.51	11.33	8.63

Data Source: S&P Global Market Intelligence Last updated: Aug 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 10, 2026

Data Sources Report a data error